Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daphne Hessels

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Asian Journal of Andrology|March 26, 2013
Urinary biomarkers for prostate cancer: a reviewDaphne Hessels, Jack A Schalken
Nature Reviews. Urology|May 9, 2009
The use of PCA3 in the diagnosis of prostate cancerDaphne Hessels, Jack A Schalken
Current Urology Reports|April 30, 2013
Recurrent gene fusions in prostate cancer: their clinical implications and usesDaphne Hessels, Jack A Schalken
Urology|November 11, 2003
New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific geneJack A Schalken, Daphne Hessels, Gerald Verhaegh
BMC Urology|December 1, 2019
Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reportsPieter Minnee, Daphne Hessels, Jack A Schalken, et al.
Expert Review of Molecular Diagnostics|July 1, 2004
Applicability of biomarkers in the early diagnosis of prostate cancerDaphne Hessels, Gerald W Verhaegh, Jack A Schalken, et al.
The Prostate|September 18, 2009
Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancerMaciej Salagierski, Gerald W Verhaegh, Sander A Jannink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancerDaphne Hessels, Frank P Smit, Gerald W Verhaegh, et al.
The Prostate|June 8, 2012
Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosisGrégoire Robert, Sander Jannink, Frank Smit, et al.
The Prostate|July 10, 2009
Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot studyMartijn P M Q van Gils, Daphne Hessels, W Pim Peelen, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Asian Journal of Andrology|March 26, 2013
Urinary biomarkers for prostate cancer: a reviewDaphne Hessels, Jack A Schalken
Nature Reviews. Urology|May 9, 2009
The use of PCA3 in the diagnosis of prostate cancerDaphne Hessels, Jack A Schalken
Current Urology Reports|April 30, 2013
Recurrent gene fusions in prostate cancer: their clinical implications and usesDaphne Hessels, Jack A Schalken
Urology|November 11, 2003
New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific geneJack A Schalken, Daphne Hessels, Gerald Verhaegh
BMC Urology|December 1, 2019
Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reportsPieter Minnee, Daphne Hessels, Jack A Schalken, et al.
Expert Review of Molecular Diagnostics|July 1, 2004
Applicability of biomarkers in the early diagnosis of prostate cancerDaphne Hessels, Gerald W Verhaegh, Jack A Schalken, et al.
The Prostate|September 18, 2009
Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancerMaciej Salagierski, Gerald W Verhaegh, Sander A Jannink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancerDaphne Hessels, Frank P Smit, Gerald W Verhaegh, et al.
The Prostate|June 8, 2012
Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosisGrégoire Robert, Sander Jannink, Frank Smit, et al.
The Prostate|July 10, 2009
Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot studyMartijn P M Q van Gils, Daphne Hessels, W Pim Peelen, et al.
Pageof 3